GUANGDONG KANGHUA HEALTHCARE CO., LTD. Guangdong Kanghua Healthcare Co., Ltd. Share Price
Equities
3689
CNE100002B55
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.1 HKD | +0.48% |
|
0.00% | +7.14% |
| Sales 2021 | 1.95B 270M 2.11B 21.59B | Sales 2022 | 1.85B 255M 1.99B 20.4B | Capitalization | 532M 73.36M 574M 5.88B |
|---|---|---|---|---|---|
| Net income 2021 | 94M 12.97M 102M 1.04B | Net income 2022 | 61M 8.42M 65.9M 674M | EV / Sales 2021 | 0.29 x |
| Net cash position 2021 | 226M 31.17M 244M 2.5B | Net cash position 2022 | 298M 41.07M 321M 3.29B | EV / Sales 2022 | 0.13 x |
| P/E ratio 2021 |
8.32
x | P/E ratio 2022 |
8.71
x | Employees | 3,946 |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 15.99% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +0.48% | ||
| Current month | -3.67% | ||
| 3 months | -4.55% | ||
| 6 months | +7.69% | ||
| Current year | +7.14% |
1 week
2.00
2.10
1 month
2.002.40
Current year
1.882.40
1 year
1.042.40
3 years
1.046.60
5 years
1.046.60
10 years
1.0414.20
| Managers | Title | Age | Since |
|---|---|---|---|
Wang Zhi Chen
CEO | Chief Executive Officer | 53 | 30/11/15 |
Wai Hang Wong
DFI | Director of Finance/CFO | 45 | 30/11/15 |
Kege Tian
CTO | Chief Tech/Sci/R&D Officer | 70 | 31/05/16 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jun Yang Wang
CHM | Chairman | 42 | 30/11/15 |
Wang Zhi Chen
CEO | Chief Executive Officer | 53 | 30/11/15 |
Wai Hung Wong
BRD | Director/Board Member | 35 | 30/11/15 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 2.1 | +0.48% | 482,800 |
| 25/04/24 | 2.09 | +4.50% | 10,200 |
| 24/04/24 | 2 | -4.31% | 200 |
| 23/04/24 | 2.09 | +4.50% | 100,800 |
| 22/04/24 | 2 | -4.76% | 200 |
Delayed Quote Hong Kong S.E., April 26, 2024 at 09:08 am
More quotes
Guangdong Kanghua Healthcare Co Ltd is a company mainly engaged in hospital business. The Company operates in four segments. Hospital Services segment mainly operates in Kanghua Hospital, providing inpatient medical care, outpatient medical care and physical examination services. Rehabilitation and Other Healthcare Services segment mainly provides rehabilitation services such as nursing care, training for the disabled, and other medical-related services for patients with physical and mental disabilities. Sales of Pharmaceutical products segment mainly sells pharmaceuticals and medical consumables to patients. Others segment is mainly engaged in elderly medical and healthcare services. The Company mainly operates two hospitals, namely Kanghua hospital and Renkang hospital.
Calendar
29/08/2024
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +7.14% | 89.7M | |
| -20.16% | 16.21B | |
| +4.50% | 12.44B | |
| +3.98% | 11.58B | |
| +9.72% | 10.79B | |
| +23.61% | 8.26B | |
| -2.19% | 7.68B | |
| +20.75% | 7.2B | |
| +4.49% | 6.67B | |
| +50.89% | 4.66B |
- Stock Market
- Equities
- 3689 Stock
